Get answers for your health queries from top Doctors for FREE!

100% Privacy Protection

100% Privacy Protection

We maintain your privacy and data confidentiality.

Verified Doctors

Verified Doctors

All Doctors go through a stringent verification process.

Quick Response

Quick Response

All Doctors go through a stringent verification process.

Reduce Clinic Visits

Reduce Clinic Visits

Save your time and money from the hassle of visits.

Ask Free Question

  1. Home >
  2. Blogs >
  3. Ovarian Dysgerminoma: Insights into the Rare Tumor
  • Cancer

Ovarian Dysgerminoma: Insights into the Rare Tumor

By Shweta Kulshreshtha| Last Updated at: 7th Nov '23| 16 Min Read

How Common Is Ovarian Dysgerminoma?

Ovarian dysgerminoma is a rare and specific type of ovarian tumour. It falls under germ cell tumours. It strikes women in their teens and early twenties. It represents only about 2% of the total cases. However, it demands attention. They're responsible for 32.8% of malignant ovarian germ cell tumours.

It accounts for a mere 1–5% of all ovarian cancers. These tumours occur during a woman's reproductive years. The incidence hovers between 2.8 and 11 cases per 100,000 pregnancies. Thus emphasizing the rarity of this condition.

Young patient discussing about Ovarian Dysgerminoma with doctor

Ovarian dysgerminomas are unique. Even though they're rare, they respond well to treatments like radiation and chemotherapy. This makes their outlook better compared to other ovarian cancers. Most people, about 90%, diagnosed it early in Stage I, when it hadn't spread. This gives it a strong chance of beating it.

The good news continues when looking at survival rates. 

If diagnosed early, the 5-year survival rate is over 95%. And it rarely comes back, especially if found in just one ovary. Mostly, young women in their late teens to early 30s get it. It's a small portion of all ovarian cancers, only about 1–5%. But it's crucial to know about it and diagnose it early.

Some intriguing insights into ovarian dysgerminoma

What Are the Early Signs and Symptoms of Ovarian Dysgerminoma?

The early signs and symptoms of ovarian dysgerminoma can be somewhat nonspecific. This makes diagnosis challenging. Some of the early signs and symptoms are:

  • Pelvic pain or discomfort
  • Abdominal bloating.
  • Swelling or a mass in the lower abdomen.
  • Irregular menstrual periods.
  • Nausea and vomiting

Signs and Symptoms of Ovarian Dysgerminoma

  • Unexplained weight loss.
  • Changes in urinary habits.
  • Fatigue.
  • Pain during sexual intercourse.
  • Elevated levels of certain hormones
  • Breast tenderness
  • Abnormal hair growth.

Early diagnosis and treatment of ovarian dysgerminoma can lead to a good prognosis. Did you notice any such symptoms?

Don't worry, schedule your appointment today

What Are the Causes and Risk Factors of Ovarian Dysgerminoma?

Ovarian dysgerminoma is an uncommon ovarian tumour. Though rare, it's the top malignant germ cell tumor in the ovary. The exact reason why it develops is a mystery, but some things might raise the risk.

 

Causes: Experts still do not fully grasp why ovarian dysgerminoma happens. It's believed that DNA changes in ovarian cells might trigger it. These changes cause cells to grow wildly, forming tumors. The detailed genetic reasons behind it remain a puzzle.

Causes and Risk Factors of Ovarian Dysgerminoma

Risk Factors:

Age: These tumors often appear in young women under 30.

Gonadal Dysgenesis: Women with this condition have ovaries that didn't grow right. It heightens the risk. Turner syndrome, a specific type of this condition, also increases the risk.

Swyer Syndrome: People with this have female looks outside but male organs inside that didn't grow right. This raises the chance of these tumors.

Family Ties: If your family has had germ cell tumors, your risk might be higher. But this link isn't proven yet.

Other Conditions: There's a hint that things like polycystic ovary syndrome (PCOS) might raise the risk. But it's not proven yet.

Even with these risk factors, it doesn't mean you'll get this tumor. Many with risks don't get it. And many who get it don't have clear risks. It's essential to stay aware and check any concerns with a doctor.

Don't stop scrolling.

The Road to recovery, what lies ahead.

How is ovarian dysgerminoma diagnosed?

The diagnosis of ovarian dysgerminoma involves the following:

Medical History: including any relevant symptoms, risk factors, and family history of cancer.

Physical Examination: Size and condition of the ovaries and any abnormalities

Imaging Studies

Ultrasonography: transvaginal ultrasound for size, location, and tumour characteristics.

Diagnosis of ovarian dysgerminoma

Computed tomography (CT) / MRI: for the tumor's extent and any potential spread to nearby structures or lymph nodes.

Blood tests, tumour markers and biopsy are also carried out.

Early detection and diagnosis of ovarian dysgerminoma are crucial for effective treatment. 

So what are you waiting for? If you notice any ovarian dysgerminoma symptom, connect with your doctor and get the screening tests done promptly!

What are the treatment options for ovarian dysgerminoma?

Treatment options for ovarian dysgerminoma may include:

  • Surgery:

Oophorectomy: Surgical removal of the affected ovary (oophorectomy) is often done if the tumour is in one ovary and its early stages.

surgery for ovarian dysgerminoma

Bilateral Salpingo-Oophorectomy: in more advanced cases or on both ovaries, both ovaries and fallopian tubes were removed. It prevents recurrence or spread.

  • Lymph Node Dissection: Done to check for the spread of cancer to nearby lymph nodes. 
  • Chemotherapy: For advanced or high-risk cases 
  • Fertility Preservation: In young women, fertility-sparing surgery is considered.
  • Radiation Therapy: when the tumor is unresectable or if there's a recurrence.

Take the first step toward recovery by contacting us for your treatment.

What is the Prognosis and Survival Rate for Ovarian Dysgerminoma Patients?

The prognosis and survival rate are generally quite favorable when the diagnosed tumour is treated in its early stages. But depends on the stage at diagnosis and the extent of spread.

Here are some key points:

  • Stage at diagnosis: Patients with stage I or stage II dysgerminomas have a very high survival rate, often exceeding 90-95%. In advanced stages (III and IV), the prognosis may be less favourable but is still relatively good compared to other ovarian cancers.

Survival Rate for Ovarian Dysgerminoma Patients

  • Age at diagnosis: Dysgerminomas typically occur in young women and girls. Younger patients tend to have a better prognosis than older patients. Also, the tumour is often less aggressive in this age group.
  • Tumor size and characteristics: The size of the tumor, rate of growth and the presence of specific markers can influence the prognosis. Smaller tumors and those with less aggressive features often have a better outcome.
  • Treatment and response: Surgery to remove the affected ovary or ovaries

 study found that the overall 5-year and 10-year survival rates were 95.1% and 91.7%, respectively.

  • Follow-Up Care: Regular follow-up appointments are essential to monitor for any signs of recurrence or complications. These may involve imaging studies (like CT scans or MRIs) and blood tests to assess tumor markers (such as LDH and AFP).

Early diagnosis and treatment of ovarian dysgerminoma leads to good prognosis and most patients can be cured.

Take charge of your health and your life. Contact us today!

Wondering if it will affect your fertility?

What Are the Long-term Implications of Ovarian Dysgerminoma?

The long-term implications of Ovarian Dysgerminoma are:

Infertility: Ovarian dysgerminoma commonly requires surgical removal of one or both ovaries, leading to infertility in affected individuals.  

Regular Follow-Up Care: Long-term implications necessitate regular follow-up appointments to check for cancer recurrence and monitor the individual's overall health and well-being.

Hormonal Imbalances: It may disrupt hormonal balance in the body, potentially leading to symptoms such as irregular menstruation, hot flashes, and mood swings. These hormonal imbalances can persist long-term and may require management.

Emotional and Psychological Impact: Individuals may experience anxiety, depression, or fear of cancer recurrence, which can affect their quality of life.

Treatment Outcomes: Long-term implications can vary based on the stage of the cancer at diagnosis and the effectiveness of treatment. Early-stage, successfully treated cases. With minimally invasive surgery, there are fewer long-term complications than advanced or recurrent cases.

 

The treatment plans should be personalised according to your specific situation.

Patient discussing fertility issues due to Ovarian Dysgerminoma

 

How Can Ovarian Dysgerminoma Impact Fertility and Pregnancy?

Ovarian dysgerminoma affects fertility in various ways. Here's a breakdown of the treatments and their impacts:

  • Surgery: Removing one or both ovaries is often necessary. This can significantly change a woman's ability to have kids.
  • Chemotherapy: This is a usual treatment. It can harm fertility either for a while or forever.
  • Saving Fertility: There are ways to help. Doctors might suggest surgery that spares fertility. Some fertility preservation techniques, like freezing eggs and saving embryos and eggs in a frozen state, are available.
  • Menstrual Return: About 9 months after treatment, many women get their periods back. This is a good sign they might be able to have kids.
  • Natural Birth: Many women can still have kids after treatment. But the individual cases must be different.
  • Pregnancy Care: If a survivor gets pregnant, doctors will watch closely. There might be health issues from the treatment that need attention.

If you're facing this condition and hope to have kids, discuss your options with a specialist. They can guide you on the best steps to take.





 

References:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983548/

https://journals.lww.com/md-journal/Fulltext/2021/04090/Ovarian_dysgerminoma_in_pregnancy__A_case_report.61.aspx

https://journals.sagepub.com/doi/10.1177/8756479315599082

https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-020-00674-z

https://ijgc.bmj.com/content/32/11/1490

Related Blogs

Question and Answers

. Heterogeneous Soft Tissue Nodule in the Right Lower Lobe (RLL) Size: 14 x 8 mm This nodule is described as heterogeneously enhancing, which suggests it may have varying levels of blood flow or different tissue densities within it. This could be indicative of a tumor. 2. Air Space Opacification in the Right Upper Lobe (RUL) Finding: There is patchy air space opacification with interlobular septal thickening in the posterior segment of RUL. This could represent infection, inflammation, or more concerningly, metastatic disease or lung cancer causing these changes. 3. Left-sided Pleural Effusion and Subsegmental Atelectasis Pleural Effusion: Mild left-sided pleural effusion is noted. Pleural effusion can occur in the context of metastatic disease or cancer. Atelectasis: This refers to partial lung collapse, which may occur when there is a mass obstructing the airflow or due to pleural fluid. 4. Enlarged Mediastinal and Hilar Lymph Nodes Lymphadenopathy: There are multiple enlarged and necrotic lymph nodes, most notably in the right hilar region, with the largest measuring 35 x 25 mm. Enlargement and necrosis of lymph nodes can be a sign of metastatic spread. The presence of enlarged lymph nodes in the mediastinum and hilum is typical of malignancy spreading beyond the primary lung site. 5. Liver Lesion Size: 14 x 13 mm lesion in the right hepatic lobe, which is well-defined and peripherally enhancing. A hypodense lesion could indicate a metastatic tumor, especially since it shows peripheral enhancement, a characteristic of some types of metastases. 6. Skeletal Lesions Multiple Lesions: There are mixed lytic and sclerotic bony lesions, some with soft tissue components. These lesions involve the vertebrae, ribs, glenoids, sternum, sacral ala, iliac bones, and femur. Soft Tissue Components: Some of the lesions, such as those in the ribs and iliac bones, have a soft tissue component, which suggests more advanced involvement, possibly indicating metastases. 7. Other Findings: No signs of emphysema, bronchiectasis, or pneumothorax were noted, which is reassuring as it reduces the likelihood of certain types of lung diseases. The liver, spleen, pancreas, kidneys, urinary bladder, and prostate all appear normal on imaging, which helps to rule out major issues in these organs. Impression: The findings of a heterogeneously enhancing solitary pulmonary nodule in the right lung, with associated hilar and mediastinal lymphadenopathy, along with a hepatic lesion and extensive skeletal involvement (with mixed lytic and sclerotic lesions), strongly raise concern for metastatic disease, most likely originating from the lung. The primary lung cancer is a potential consideration, though other primary sites are also possible. Next Steps: Histopathological correlation: This means a biopsy or tissue sample should be taken from one of the lesions (pulmonary, hepatic, or bone) to confirm whether the lesions are malignant and, if so, to identify the type of cancer. This will help determine the best course of treatment. The overall picture suggests a metastatic malignancy, likely of pulmonary origin, but further investigations and biopsy are essential to establish a definitive diagnosis and treatment plan.

Male | 58

Answered on 8th Mar '25

Read answer

Cancer Hospitals In Other Cities

Top Related Speciality Doctors In Other Cities

Cost Of Related Treatments In Country

Consult